CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation
- 3 Insider Initial Statement of Ownership
- 8-K/A Event Executive or director change
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 222,222 shares at $0.45 ($100,000)
- 8-K Event Material agreement · Unregistered share sale
- DEFA14A Proxy Proxy Materials
- 4 Other acquisition Director acquired 11,112 shares (other)
- 4/A Open-market buy Director bought 16,389 shares at $0.45 ($7,375)
- 4/A Open-market buy Director bought 55,556 shares at $0.45 ($25,000)
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
Page 1 of 78 · 1,549 filings